Device Trial Radar · NCT05836844
Pragmatic Evaluation of Performance and Safety of the Anchorsure® Transvaginal Device for Surgical Treatment of Apical Prolapse in Women
Last checked: Nov 20, 2026Latest source record: Nov 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
May 11, 2023
Primary completion
Oct 1, 2024
Study completion Jun 1, 2028
Sponsor
- Lead sponsor
- Centre Hospitalier Universitaire de NīmesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University Hospital, Lille; Kremlin-Bicetre Hospital, Paris; Clinique Sainte-Anne, Strasbourg; Centre Hospitalier de La Rochelle
- First posted
- May 1, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 50 years
Summary
As written by the sponsor on the registry.
Pelvic Organ Prolapse affects 50% of parous women, and apical prolapse is one of the most common types of prolapse. Treatment for apical prolapse ranges from observation, non-surgical treatment or surgical repair. An anchoring device can reduce dissection and operative time and is meant to provide strong fixation whilst minimizing potential postoperative pain by avoiding neurovascular injuries. These potential advantages must be evaluated in terms of performance and safety. This cohort study will be on patients undergoing sacrospinous fixation with the Anchorsure® system with a follow-up of 36 months.
Conditions
- Prolapse; Female
- Prolapse Uterovaginal
- Prolapse; Cervix
Interventions
The Anchorsure System®Device
Sacrospinous ligament fixation performed with the Anchorsure Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful performance after sacrospinous fixation of the Anchorsure System®.Time frame: 12 months after fixation
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
La Rochelle General Hospital
La Rochelle, France · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.